The fusion protein of HSP65 with tandem repeats of β-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma

International Immunopharmacology

Volumn 10, Issue 2, 2010, Pages 230-238

  Xiangbing, Hu ^a   Yankai, Zhang ^a   Ming, Lin ^a   Yong, Lu ^a   Yu, Zhang ^a   Huiyong, Zhang ^a   Yingying, Chen ^a   Jing, Hou ^a   Yun, Xing ^a   Liang, Jin ^a   Rongyue, Cao ^a   Jingjing, Liu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; HSP65; Human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; HEAT SHOCK PROTEIN 65; HSP65 X10 BETA HCGCTP37 PROTEIN; HYBRID PROTEIN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CANCER INHIBITION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMORAL IMMUNITY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CHAPERONIN 60; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; LIVER NEOPLASMS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; TANDEM REPEAT SEQUENCES;

EID: 74849113541     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.11.006     Document Type: Article

References (57)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 9399 (Dec 6 2003) 1907-1917
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 55 2 (Mar-Apr 2005) 74-108
3. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 5 Suppl 1 (Nov 2004) S27-S34
4. Wong C.M., and Ng I.O. Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28 2 (Feb 2008) 160-174
5. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 9 (Sep 2006) 674-687
6. Yuji I., Taro S., Rysuke I., Katsuhiko Y., and Katsuhiko Y. Anti-angiogenic therapy on hepatocellular carcinoma development and progression. J Surg Res (2008)
7. Okuda K., Ohtsuki T., Obata H., Tomimatsu M., Okazaki N., Hasegawa H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 4 (Aug 15 1985) 918-928
8. Berger P., Sturgeon C., Bidart J.M., Paus E., Gerth R., Niang M., et al. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 23 1 (Jan-Feb 2002) 1-38
9. Morinaga S., Yamaguchi M., Watanabe I., Kasai M., Ojima M., and Sasano N. An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin. Cancer 51 9 (May 1 1983) 1647-1652
10. Iles R.K. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol 260-262 (Jan 2 2007) 264-270
11. Yu N., Xu W., Jiang Z., Cao Q., Chu Y., and Xiong S. Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin beta. Immunol Lett 114 2 (Dec 15 2007) 94-102
12. Gillott D.J., Iles R.K., and Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 73 3 (Feb 1996) 323-326
13. Triozzi P.L., and Stevens V.C. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep 6 1 (Jan-Feb 1999) 7-17
14. Rotzschke O., Falk K., and Strominger J.L. Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc Natl Acad Sci U S A 94 26 (Dec 23 1997) 14642-14647
15. Li D., Li H., Zhang P., Wu X., Wei H., Wang L., et al. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Eur J Immunol 36 5 (May 2006) 1324-1336
16. Hsu C.T., Ting C.Y., Ting C.J., Chen T.Y., Lin C.P., Whang-Peng J., et al. Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res 60 14 (Jul 15 2000) 3701-3705
17. Gutierrez Banos J.L., Rebollo Rodrigo M.H., Antolin Juarez F.M., and Martin Garcia B. NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study. Urol Int 66 4 (2001) 185-190
18. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2 3 (Mar 2002) 185-194
19. Walker K.B., Keeble J., and Colaco C. Mycobacterial heat shock proteins as vaccines - a model of facilitated antigen presentation. Curr Mol Med 7 4 (Jun 2007) 339-350
20. Yankai Z., Rong Y., Yi H., Wentao L., Rongyue C., Ming Y., et al. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Biochem Biophys Res Commun 345 4 (Jul 14 2006) 1365-1371
21. Einstein M.H., Kadish A.S., Burk R.D., Kim M.Y., Wadler S., Streicher H., et al. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol 106 3 (Sep 2007) 453-460
22. Hsueh E.C., Gupta R.K., Qi K., and Morton D.L. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine. J Clin Oncol 16 9 (Sep 1998) 2913-2920
23. Yang W., Guo C., Liu Q.G., and Pan C. Experimental study of specific immunotherapy induced by H22 autologous tumor as whole tumor cell vaccine. Biomed Pharmacother 63 6 (July 2009) 404-408
24. Kreisle R.A., and Ershler W.B. Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. J Natl Cancer Inst 80 11 (Aug 3 1988) 849-854
25. Anthony L.S., Wu H., Sweet H., Turnnir C., Boux L.J., and Mizzen L.A. Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule. Vaccine 17 4 (Jan 28 1999) 373-383
26. Cho B.K., Palliser D., Guillen E., Wisniewski J., Young R.A., Chen J., et al. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 12 3 (2000 Mar) 263-272
27. Chen K., Lu J., Wang L., and Gan Y.H. Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leukoc Biol 75 2 (Feb 2004) 260-266
28. Gaofu Q., Dan M., Jie W., Liao Z., Li Z., Roque R.S., et al. Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants. Vaccine 22 23-24 (Aug 13 2004) 3187-3194
29. Acevedo H.F., Tong J.Y., and Hartsock R.J. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76 8 (Oct 15 1995) 1467-1475
30. Delves P.J., Iles R.K., Roitt I.M., and Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol 260-262 (Jan 2 2007) 276-281
31. Moulton H.M., Yoshihara P.H., Mason D.H., Iversen P.L., and Triozzi P.L. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res 8 7 (Jul 2002) 2044-2051
32. He L.Z., Ramakrishna V., Connolly J.E., Wang X.T., Smith P.A., Jones C.L., et al. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta. Clin Cancer Res 10 6 (Mar 15 2004) 1920-1927
33. Stenman U.H., Alfthan H., and Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem 37 7 (Jul 2004) 549-561
34. Oscherwitz J., Zeigler M.E., Gribbin T.E., and Cease K.B. A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein. Vaccine 17 19 (May 14 1999) 2392-2399
35. Kim H.D., Maxwell J.A., Kong F.K., Tang D.C., and Fukuchi K. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease. Biochem Biophys Res Commun 336 1 (Oct 14 2005) 84-92
36. Blachere N.E., Li Z., Chandawarkar R.Y., Suto R., Jaikaria N.S., Basu S., et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 186 8 (Oct 20 1997) 1315-1322
37. Tamura Y., Peng P., Liu K., Daou M., and Srivastava P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278 5335 (Oct 3 1997) 117-120
38. Zhang H., and Huang W. Fusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo. Cell Stress Chaperones 11(3 Autumn (2006) 216-226
39. Tobian A.A., Harding C.V., and Canaday D.H. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes. J Immunol 174 9 (May 1 2005) 5209-5214
40. Ding L., Lalani E.N., Reddish M., Koganty R., Wong T., Samuel J., et al. Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene. Cancer Immunol Immunother 36 1 (1993) 9-17
41. Blachere N.E., Zihai L., Chandawarkar R.Y., Ryuichiro S., Jaikaria N.S., Sreyashi B., et al. Heat shock protein peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186 8 (1997 October 20) 1315-1322
42. Srivastava P.K., and Das M.R. The serologically unique cell-surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33 3 (Mar 15 1984) 417-422
43. Cho B.K., Palliser D., Guillen E., Wisniewski J., Young R.A., Jianzhu C., et al. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 12 (2000) 263-272
44. Suto R., and Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science (Wash. DC) 269 (1995 Sep) 1585-1588
45. Iles R.K., and Chard T. Molecular insights into the structure and function of human chorionic gonadotrophin. J Mol Endocrinol 10 3 (Jun 1993) 217-234
46. Kosaka K., Fujiwara H., Tatsumi K., Yoshioka S., Sato Y., Egawa H., et al. Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system. J Clin Endocrinol Metab 87 11 (Nov 2002) 5199-5208
47. Butler S.A., Staite E.M., and Iles R.K. Reduction of bladder cancer cell growth in response to hCGbeta CTP37 vaccinated mouse serum. Oncol Res 14 2 (2003) 93-100
48. Shojaei F., Zhong C., Wu X., Yu L., and Ferrara N. Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18 8 (2008 Aug) 372-378
49. Li C.Y., Shan S., Huang Q., Braun R.D., Lanzen J., Hu K., et al. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92 2 (Jan 19 2000) 143-147
50. Arrieta O., Ortega R.M.M., Ángeles-Sánchez J., Villarreal-Garza C., Avilés-Salas A., Chanona- Vilchis J.G., et al. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors. J Exp Clin Cancer Res 28 (2009) 120
51. Stetler-Stevenson W. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103 (1999) 1237-1241
52. Stetler-Stevenson W.G., and Yu A.E. Proteases in invasion: matrix metalloproteinases. Semin Cancer Bio l 11 (2001) 143-152
53. Liotta L., Steeg P., and Stetler-Stevenson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
54. Lah J.J., Cui W., and Hu K. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 13 (2007) 5299-5305
55. Pfeffer U., Bisacchi D., Morini M., Benelli R., Minghelli S., Vacca A., et al. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. Endocrinology 143 8 (August 2002) 3114-3121
56. GuiFu W., Jincai L., Rana J.S., Roger L., Sellke F.W., and Jian L. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 69 (2006) 512-519
57. Cheng A.S., Chan H.L., To K.F., Leung W.K., Chan K.K., Liew C.T., et al. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int J Oncol 24 (2004) 853-860